Bozca, B. C. Et Al. 2022. Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus. Journal of Dermatological Treatment , vol.33, no.4 , 2102-2109.

Bozca, B. C., Bilgiç, A., & UZUN, S., (2022). Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus. Journal of Dermatological Treatment , vol.33, no.4, 2102-2109.

Bozca, BURÇİN, Aslı Bilgiç, And SONER UZUN. "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus," Journal of Dermatological Treatment , vol.33, no.4, 2102-2109, 2022

Bozca, BURÇİN C. Et Al. "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus." Journal of Dermatological Treatment , vol.33, no.4, pp.2102-2109, 2022

Bozca, B. C. Bilgiç, A. And UZUN, S. (2022) . "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus." Journal of Dermatological Treatment , vol.33, no.4, pp.2102-2109.

@article{article, author={BURÇİN CANSU BOZCA Et Al. }, title={Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus}, journal={Journal of Dermatological Treatment}, year=2022, pages={2102-2109} }